First Clinical Medical College, Lanzhou University, Lanzhou, China (XX Jiang, Dr B Wang and Shen, XX Wu, XX He, Dr Liu, and Zhang).
The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China (Dr L Wang, Y Wang, and Zhang); Key Laboratory for Reproductive Medicine and Embryo of Gansu Province, Lanzhou, China (Dr L Wang, Y Wang, and Zhang).
Am J Obstet Gynecol MFM. 2023 Jan;5(1):100762. doi: 10.1016/j.ajogmf.2022.100762. Epub 2022 Oct 8.
The aim of this systematic review and meta-analysis was to analyze the reproductive outcomes of natural pregnancy after hysteroscopic septum resection in patients with recurrent miscarriage, primary infertility, or secondary infertility.
The PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, VIP Database, and Chinese Biomedical Literature Database (CBM) databases were electronically searched. The search time frame was from inception up to July 2021. The English search terms were (arcuate* and uter*), (sept* and uter*), (subseptate* and uter*), metroplast*, septoplast*, and resect*.
Selection criteria included randomized controlled trials, cohort studies, and case series that explored reproductive outcomes after hysteroscopic septum resection in patients with recurrent miscarriage, primary infertility, or secondary infertility with or without a control group.
The primary outcomes were the live birth rate and eventual postoperative live birth rate after hysteroscopic septum resection. The secondary outcomes were the clinical pregnancy rate, preterm birth rate, and miscarriage rate. Study-level proportions of outcomes were transformed using the Freeman-Tukey double-arcsine transformation to calculate pooled values for the postoperative rates; the counted data were analyzed using relative risk as the effect analysis statistic, and each effect size was provided with its 95% confidence interval. Heterogeneity between the results of the included studies was analyzed using the I test.
Overall, 5 cohort studies and 22 case series involving 1506 patients were included. In patients with a septate uterus and recurrent miscarriage, hysteroscopic septum resection was associated with an increased live birth rate (relative risk, 1.77; 95% confidence interval, 1.26-2.49; P=.001; I=0%), resulting in a postoperative live birth rate of 66% (95% confidence interval, 59-72), and septum resection was associated with a reduced preterm birth rate (relative risk, 0.15; 95% confidence interval, 0.04-0.53; P=.003; I=0%) and miscarriage rate (relative risk, 0.36; 95% confidence interval, 0.20-0.66; P=.0009; I=0%). In patients with a septate uterus and primary infertility, hysteroscopic septum resection was associated with an increased live birth rate (relative risk, 4.12; 95% confidence interval, 1.19-14.29; P=.03; I=0%) and clinical pregnancy rate (relative risk, 2.28; 95% confidence interval, 1.04-4.98; P=.04; I=0%). The postoperative live birth rate was 37% (95% confidence interval, 30-44), and the miscarriage rate of patients with primary infertility was reduced (relative risk, 0.19; 95% confidence interval, 0.06-0.56; P=.003). The efficacy of hysteroscopic septum resection in patients with secondary infertility was unclear. However, their postoperative live birth rate was found to be 41% (95% confidence interval, 2-88).
Hysteroscopic septum resection is associated with an increased live birth rate and a reduced miscarriage rate in patients with recurrent miscarriage or primary infertility, indicating that septum resection may improve the reproductive outcomes of these patients. The effectiveness of septum resection was unclear for patients with secondary infertility. These findings are limited by the quality of the included studies, warranting further randomized controlled trials, including only patients with recurrent miscarriage or primary infertility.
本系统评价和荟萃分析旨在分析宫腔镜下子宫纵隔切除术治疗复发性流产、原发性不孕或继发性不孕患者的生殖结局。
电子检索了 PubMed、Embase、Cochrane 图书馆、Web of Science、中国国家知识基础设施(CNKI)、万方数据知识服务平台、VIP 数据库和中国生物医学文献数据库(CBM)数据库。检索时间范围为从建库到 2021 年 7 月。英文检索词为(arcuate和 uter)、(sept和 uter)、(subseptate和 uter)、metroplast*、septoplast和 resect。
选择标准包括随机对照试验、队列研究和病例系列研究,这些研究探讨了宫腔镜下子宫纵隔切除术治疗复发性流产、原发性不孕或继发性不孕患者的生殖结局,并与对照组进行了比较。
主要结局为宫腔镜下子宫纵隔切除术后的活产率和最终术后活产率。次要结局为临床妊娠率、早产率和流产率。使用 Freeman-Tukey 双反正弦变换转换研究水平的结局比例,以计算术后率的汇总值;使用相对风险作为效应分析统计量分析计数数据,为每个效应量提供其 95%置信区间。使用 I 检验分析纳入研究结果之间的异质性。
共有 5 项队列研究和 22 项病例系列研究纳入了 1506 例患者。在子宫纵隔伴复发性流产的患者中,宫腔镜下子宫纵隔切除术与活产率增加相关(相对风险,1.77;95%置信区间,1.26-2.49;P=0.001;I=0%),术后活产率为 66%(95%置信区间,59-72),且与早产率降低相关(相对风险,0.15;95%置信区间,0.04-0.53;P=0.003;I=0%)和流产率降低相关(相对风险,0.36;95%置信区间,0.20-0.66;P=0.0009;I=0%)。在子宫纵隔伴原发性不孕的患者中,宫腔镜下子宫纵隔切除术与活产率增加相关(相对风险,4.12;95%置信区间,1.19-14.29;P=0.03;I=0%)和临床妊娠率增加相关(相对风险,2.28;95%置信区间,1.04-4.98;P=0.04;I=0%)。术后活产率为 37%(95%置信区间,30-44),且原发性不孕患者的流产率降低(相对风险,0.19;95%置信区间,0.06-0.56;P=0.003)。宫腔镜下子宫纵隔切除术治疗继发性不孕的疗效尚不清楚。然而,他们的术后活产率为 41%(95%置信区间,2-88)。
宫腔镜下子宫纵隔切除术与复发性流产或原发性不孕患者的活产率增加和流产率降低相关,表明子宫纵隔切除术可能改善这些患者的生殖结局。子宫纵隔切除术治疗继发性不孕的有效性尚不清楚。这些发现受到纳入研究质量的限制,需要进一步的随机对照试验,仅纳入复发性流产或原发性不孕患者。